QNRX – quoin pharmaceuticals, ltd. - american depositary shares (US:NASDAQ)
Stock Stats
News
Quoin Pharmaceuticals Announces Submission to Japanese MHLW for Orphan Drug Designation for QRX003 in Netherton Syndrome
Quoin Pharmaceuticals Files Breakthrough Medicine Designation Application in Saudi Arabia for QRX003 in Netherton Syndrome
Quoin Pharmaceuticals (NASDAQ:QNRX) had its "sell (e+)" rating reaffirmed by analysts at Weiss Ratings.
Form SCHEDULE 13G/A Quoin Pharmaceuticals, Filed by: INTEGRATED CORE STRATEGIES (US) LLC
Form SCHEDULE 13G/A Quoin Pharmaceuticals, Filed by: Ikarian Capital, LLC
Form 4 Quoin Pharmaceuticals, For: Feb 04 Filed by: Lawlor Sally Bridget
Form 4 Quoin Pharmaceuticals, For: Feb 04 Filed by: Cooper Joseph Patrick
Form 4 Quoin Pharmaceuticals, For: Feb 04 Filed by: Culverwell Anthony James
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.